搜索临床试验以:Solid tumour
总计9609个结果
-
OSE ImmunotherapeuticsBoehringer Ingelheim主动,不招人
-
Canadian Cancer Trials GroupPfizer完全的
-
AstraZenecaImaginAb, Inc.终止
-
Eisai Limited完全的卵巢癌 | 三阴性乳腺癌 | 恶性实体瘤 | 晚期黑色素瘤 | B 细胞恶性肿瘤,低级别英国
-
Basilea PharmaceuticaArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck &...完全的
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody AS完全的
-
National Cancer Centre, SingaporeNovartis完全的
-
Assistance Publique Hopitaux De Marseille完全的
-
Laminar PharmaceuticalsRoyal Marsden NHS Foundation Trust; Vall d'Hebron Institute of Oncology; Specialized Medical Services... 和其他合作者完全的
-
The University of Texas Health Science Center at...Merck Sharp & Dohme LLC完全的
-
Institut BergoniéNational Cancer Institute, France; Institut du Cancer de Montpellier - Val d'Aurelle; Centre Georges...主动,不招人
-
Palobiofarma SLVall d'Hebron institute of oncology (VHIO), Catalan institute of oncology (Hospitalet) (ICO)完全的
-
Xennials Therapeutics Australia Pty LtdPinotbio, Inc.终止
-
University Hospital TuebingenDeutsche Kinderkrebsstiftung; Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany 和其他合作者完全的
-
SOLTI Breast Cancer Research GroupNovartis; Roche Pharma AG; Guardant Health, Inc.主动,不招人
-
Oxford University Hospitals NHS TrustUniversity of Oxford; Cancer Research UK; National Institute for Health Research, United Kingdom完全的
-
AstraZenecaSyneos Health完全的
-
AstraZenecaParexel终止
-
Imperial College London4D pharma plc主动,不招人
-
Peter MacCallum Cancer Centre, Australia完全的
-
Allarity Therapeutics完全的
-
Dr David ZieglerEngeneic Pty Limited终止